Jazz Pharmaceuticals plc – Filings and Transcripts

NASDAQ: JAZZ
Share price (8/12/26): $248.94
Market cap (8/12/26): $16.2 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025 – amended

ended 12/31/25 FY 2025

ended 09/30/25 Q3

Prospectuses and Registrations Filter

Third party tender offer – amended

Third party tender offer – amended

Third party tender offer – amended

Third party tender offer – amended

Third party tender offer – amended

Ownership Filter

Kennedy Patrick

Pearce Samantha

Smith Mark Douglas

Cook Jennifer E.

News Filter

Material Definitive Agreement, Financial Statements or Exhibits

To Acquire Actio Biosciences, Expanding Rare Epilepsy Portfolio

Announces Second Quarter 2026 Financial Results

Shareholder Vote Results

Change in Directors, Officers or Compensation

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission